Korea Investment Increased By $992,800 Its Jazz Pharmaceuticals Plc (JAZZ) Stake; Marine Products Has 0.68 Sentiment

February 15, 2018 - By Adrian Mccoy

Korea Investment Corp increased Jazz Pharmaceuticals Plc (JAZZ) stake by 30.91% reported in 2017Q3 SEC filing. Korea Investment Corp acquired 6,800 shares as Jazz Pharmaceuticals Plc (JAZZ)’s stock rose 8.72%. The Korea Investment Corp holds 28,800 shares with $4.21M value, up from 22,000 last quarter. Jazz Pharmaceuticals Plc now has $8.64B valuation. The stock decreased 1.18% or $1.72 during the last trading session, reaching $144.12. About 77,368 shares traded. Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has risen 1.25% since February 15, 2017 and is uptrending. It has underperformed by 15.45% the S&P500.

Marine Products Corporation designs, makes, and sells recreational fiberglass powerboats for the sportboat, deckboat, cruiser, sport yacht, jet boat, and sport fishing markets worldwide. The company has market cap of $498.70 million. It provides Chaparral sterndrive pleasure boats, including SSi and SSX sportboats, Sunesta sportdecks, Signature cruisers, SunCoast sportdeck outboards, Vortex Jet Boats, and Robalo outboard sport fishing boats, as well as H2O Sport, and Fish and Ski boats. It has a 26.07 P/E ratio. The firm sells its products to a network of 147 domestic and 90 international independent authorized dealers.

Among 21 analysts covering Jazz Pharmaceuticals (NASDAQ:JAZZ), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Jazz Pharmaceuticals had 71 analyst reports since August 3, 2015 according to SRatingsIntel. Wells Fargo initiated the stock with “Outperform” rating in Friday, February 19 report. The stock has “Buy” rating by BMO Capital Markets on Wednesday, June 7. As per Friday, October 9, the company rating was initiated by Mizuho. The firm earned “Buy” rating on Tuesday, January 30 by Piper Jaffray. UBS maintained the stock with “Buy” rating in Wednesday, May 11 report. The stock of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has “Buy” rating given on Wednesday, November 8 by FBR Capital. The firm has “Neutral” rating given on Wednesday, February 24 by Mizuho. BMO Capital Markets maintained the shares of JAZZ in report on Tuesday, October 24 with “Buy” rating. The rating was maintained by Mizuho on Tuesday, December 5 with “Hold”. SunTrust maintained Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) rating on Friday, November 3. SunTrust has “Buy” rating and $210.0 target.

Korea Investment Corp decreased Chevron Corp New (NYSE:CVX) stake by 32,100 shares to 1.44M valued at $169.73M in 2017Q3. It also reduced Marsh & Mclennan Cos Inc (NYSE:MMC) stake by 23,300 shares and now owns 604,409 shares. Delphi Automotive Plc (NYSE:DLPH) was reduced too.

Investors sentiment decreased to 1.03 in Q3 2017. Its down 0.36, from 1.39 in 2017Q2. It worsened, as 39 investors sold JAZZ shares while 82 reduced holdings. 31 funds opened positions while 94 raised stakes. 53.58 million shares or 3.54% more from 51.74 million shares in 2017Q2 were reported. Sei Invests owns 10,418 shares or 0.01% of their US portfolio. Maverick Cap Ltd has invested 0.04% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Moreover, Gotham Asset Mngmt Limited Liability has 0.07% invested in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) for 34,057 shares. Emerald Advisers Pa stated it has 0.06% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Endurant Capital Mngmt Limited Partnership holds 0.82% or 18,450 shares in its portfolio. Meiji Yasuda Asset Mngmt invested in 3,200 shares or 0.05% of the stock. Daiwa Gru holds 1,650 shares or 0% of its portfolio. Jpmorgan Chase And accumulated 1.67 million shares. Moreover, Clarivest Asset Lc has 0.01% invested in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Northern invested 0.01% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Gateway Inv Advisers Llc stated it has 31,771 shares. Atika Cap Mgmt Ltd Limited Liability Company has 14,500 shares for 0.61% of their portfolio. Eulav Asset Mgmt reported 0.66% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Westfield Capital Limited Partnership has invested 1.62% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Sit Investment Associate reported 0.03% stake.

Since August 14, 2017, it had 0 insider buys, and 8 selling transactions for $2.23 million activity. MILLER MICHAEL PATRICK also sold $28,876 worth of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) on Tuesday, August 15. Young Matthew P. sold 700 shares worth $106,512. COZADD BRUCE C had sold 1,000 shares worth $153,520 on Tuesday, September 12. 1,304 shares were sold by Treacy Paul, worth $186,884 on Monday, August 14. 9,000 shares were sold by ENRIGHT PATRICK G, worth $1.26 million on Monday, December 11.

The stock decreased 2.91% or $0.43 during the last trading session, reaching $14.34. About 3,917 shares traded. Marine Products Corporation (MPX) has risen 59.03% since February 15, 2017 and is uptrending. It has outperformed by 42.33% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: